Examination of a Canadian provincial prenatal HIV screening program: 2010 to 2014

OBJECTIVES: Universal prenatal screening in the Canadian province of Alberta employs an ‘opt-out’ HIV screening strategy. We examined all women giving birth in the province and determined the frequency and characteristics of women having and not having HIV screening. METHODS: All livebirths in Alber...

Full description

Bibliographic Details
Published in:Canadian Journal of Public Health
Main Authors: Plitt, Sabrina S., Smith, Trenton R., Berry, Warren, Osman, Mariam, Senthilselvan, Ambikaipakan, Charlton, Carmen L.
Format: Text
Language:English
Published: Springer International Publishing 2020
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438462/
http://www.ncbi.nlm.nih.gov/pubmed/32016920
https://doi.org/10.17269/s41997-019-00281-6
Description
Summary:OBJECTIVES: Universal prenatal screening in the Canadian province of Alberta employs an ‘opt-out’ HIV screening strategy. We examined all women giving birth in the province and determined the frequency and characteristics of women having and not having HIV screening. METHODS: All livebirths in Alberta from January 1, 2010 to December 31, 2014 were compiled from the Vital Statistics database and linked to HIV screening data to determine maternal demographic and prenatal care characteristics. Correlates associated with prenatal HIV screening, opting out of HIV screening, and not having any prenatal communicable disease screening were determined by multivariable statistics. RESULTS: Of the 256,280 live births, 94.2% had prenatal HIV screening, 1.9% declined prenatal HIV screening, and 3.9% had no record of any prenatal communicable disease testing. Compared with those who had HIV screening, those who opted out of prenatal HIV screening were more likely to be over 40 years of age (adjusted odds ratio (AOR), 2.83 [2.12–3.78]) and less likely to be single (AOR, 0.67 [0.62–0.73]) and First Nations (AOR, 0.67 [0.56–0.82]). Those who received no prenatal communicable disease screening were less likely to be over 40 years of age (AOR, 0.81 [0.69–0.95]) and more likely to be single (AOR, 1.27 [1.21–1.33]) and have received no prenatal care (AOR, 6.78 [6.40–7.19]). Both the HIV decliners and prenatal non-testers were more likely to have used a midwife (AOR, 4.52 [3.83–5.35] and AOR, 2.44 [2.03–2.92], respectively). CONCLUSION: Demographic and prenatal care characteristics differ by a pregnant woman’s prenatal screening status. Policies to improve HIV screening coverage should take these variations into account.